These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2266395)

  • 21. Indium-111-antimyosin images compared with triphenyl tetrazolium chloride staining in a patient six days after myocardial infarction.
    Jain D; Crawley JC; Lahiri A; Raftery EB
    J Nucl Med; 1990 Feb; 31(2):231-3. PubMed ID: 1690274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of chemotherapy-induced kidney disorder and antimyosin antibody uptake in kidneys.
    Reuland P; Ruck P; Feine U
    J Nucl Med; 1992 Feb; 33(2):309-11. PubMed ID: 1732461
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of indium-111 antimyosin (Fab) imaging as a noninvasive surveillance method of human heart transplant rejection.
    De Nardo D; Scibilia G; Macchiarelli AG; Cassisi A; Tonelli E; Papalia U; Gallo P; Antolini M; Pitucco G; Reale A
    J Heart Transplant; 1989; 8(5):407-12. PubMed ID: 2795283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmural uptake of perfusion tracers and infarct-specific tracers.
    Johnson LL
    J Nucl Med; 1992 Feb; 33(2):229-30. PubMed ID: 1531071
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of myocardial necrosis and inflammation by nuclear cardiac imaging.
    Taillefer R
    Cardiol Clin; 1994 May; 12(2):289-302. PubMed ID: 8033178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course of myocardial infarction evaluated by indium-111-antimyosin monoclonal antibody scintigraphy: clinical implications and prognostic value.
    Yamada T; Tamaki N; Morishima S; Konishi J; Yoshida A; Matsumori A
    J Nucl Med; 1992 Aug; 33(8):1501-8. PubMed ID: 1634942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Scintigraphy using 111In-labeled antimyosin in Churg-Strauss vasculitis with myocardial involvement].
    Krause T; Schümichen C; Beck A; Lang B; Hohnloser S; Moser E
    Nuklearmedizin; 1990 Aug; 29(4):177-9. PubMed ID: 2216812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of myocardial damage in dilated-phase hypertrophic cardiomyopathy by using indium-111-antimyosin Fab myocardial scintigraphy.
    Nishimura T; Nagata S; Uehara T; Hayashida K; Mitani I; Kumita S
    J Nucl Med; 1991 Jul; 32(7):1333-7. PubMed ID: 2066786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimyosin monoclonal antibodies for early detection of cardiac allograft rejection.
    Schuetz A; Fritsch S; Kemkes BM; Kugler C; Angermann C; Spes C; Anthuber M; Weiler A; Wenke K; Gokel JM
    J Heart Transplant; 1990; 9(6):654-61. PubMed ID: 2277304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging.
    Frist W; Yasuda T; Segall G; Khaw BA; Strauss HW; Gold H; Stinson E; Oyer P; Baldwin J; Billingham M
    Circulation; 1987 Nov; 76(5 Pt 2):V81-5. PubMed ID: 3311460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New technique for assessing muscle damage after trauma.
    Malki AA; Elgazzar A; Ashqar T; Owunwanne A; Abdel-Dayem H
    J R Coll Surg Edinb; 1992 Apr; 37(2):131-3. PubMed ID: 1377253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indium-111 antimyosin antibodies for detection of rejection and drug induced cardiomyopathies.
    Carrió I
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):56-61. PubMed ID: 1450247
    [No Abstract]   [Full Text] [Related]  

  • 33. Is In-111 antimyosin antibody a useful diagnostic marker for evaluation of early cardiac allograft rejection?
    Ueda K; Takeda K; LaFrance ND; Solez K; Baumgartner WA; Reitz BA; Herskowitz A
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):778-81. PubMed ID: 2831646
    [No Abstract]   [Full Text] [Related]  

  • 34. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
    Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
    N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary uptake in indium-111-antimyosin Fab fragment imaging following human cardiac transplantation.
    Fokke M; Hesse B; Mortensen SA
    J Nucl Med; 1994 Feb; 35(2):266-8. PubMed ID: 8294997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective right ventricular dysfunction following doxorubicin therapy.
    Sperber AD; Cantor AA; Biran H; Keynan A
    Isr J Med Sci; 1987 Aug; 23(8):896-9. PubMed ID: 3679793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ability of antimyosin scintigraphy monitoring to exclude acute rejection during the first year after heart transplantation.
    Hesse B; Mortensen SA; Folke M; Brodersen AK; Aldershvile J; Pettersson G
    J Heart Lung Transplant; 1995; 14(1 Pt 1):23-31. PubMed ID: 7727472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial imaging with Tc-99m pyrophosphate in patients with adriamycin for neoplasia.
    Soin JS
    J Nucl Med; 1978 May; 19(5):564-5. PubMed ID: 205637
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunoscintigraphy with 111-indium-labelled antimyosin antibodies in the assessment of muscle metastases. A case report].
    Ferraironi A; Tofani A; Sciuto R; Cucchi R; Crecco M; Maini CL
    Radiol Med; 1994; 87(1-2):165-8. PubMed ID: 8128026
    [No Abstract]   [Full Text] [Related]  

  • 40. [Imaging of myocardial necrosis--indium-111 labeled antimyosin monoclonal antibody imaging using single-photon emission computed tomography].
    Yamada T; Matsumori A
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):569-73. PubMed ID: 12436583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.